SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study. Anson M, Zhao SS, Austin P, Ibarburu GH, et al. Diabetologia 2023 Jul 28. doi: 10.1007/s00125-023-05975.

Read + Share

Amedeo Smart

Independent Medical Education

Anson M, Zhao SS, Austin P, Ibarburu GH, et al. SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study. Diabetologia 2023 Jul 28. doi: 10.1007/s00125-023-05975.
PMID: 37505282